|
Chris Ringwalt, DrPH
— Deputy Director of Evaluation
Dr. Ringwalt is a Senior Scientist at the Chapel Hill Center of the Pacific
Institute for Research and Evaluation (PIRE). He has 15 years of experience
in the design, development, analysis, and reporting of epidemiological,
etiological, and evaluation studies relating to public health issues.
During the 10 years he spent at RTI, his research interests focused primarily
on the prevention of adolescent and adult risk behaviors, particularly
violence and alcohol, tobacco, and other drug (ATOD) use. He has directed
evaluations of the Drug Abuse Resistance Education (DARE) Program for
the National Institute on Drug Abuse (NIDA) and the National Institute
of Justice (NIJ), and recently evaluated a community-based violence prevention
program for the Centers for Disease Control and Prevention (CDC). He has
also investigated the prevalence of ATOD use and other risk behaviors
among runaway and homeless youth, with support from the Department of
Health and Human Services (DHHS) and NIDA. He has recently concluded a
study of North Carolina's ATOD prevention needs for the Centers for Substance
Abuse Prevention (CSAP), for which he is currently evaluating a State
Incentive Grant (SIG). He has also studied the development of ethnic identity
in African-American male adolescents (for CDC), adolescent dating violence
(for the Assistant Secretary for Planning and Evaluation, or ASPE), and
drug prevention in managed care settings (for CSAP). He is currently conducting
two studies with support from NIDA, one of school-based drug prevention
programs, and the other concerning the enhancement of teacher fidelity
to evidence-based drug prevention curricula. He is also evaluating Project
SUCCESS, an indicated substance abuse prevention curriculum for high risk
adolescents, for both the Office of Juvenile Justice and Delinquency Prevention
(OJJDP) and the Chicago Public Schools. In addition, he is evaluating
Project ALERT for OJJDP. Dr. Ringwalt has served as Chair of the Alcohol,
Tobacco, and Other Drug Section of the American Public Health Association
(APHA), and as Secretary to the Board of the Society of Prevention Research.
He has just stepped down from a five year term as Director of PIREs Chapel
Hill Center.
|
